Trial Profile
Neoadjuvant therapy with FOLFIRINOX and/or gemcitabine/nab-paclitaxel in patients with advanced pancreatic cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Mar 2017
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Paclitaxel (Primary) ; Fluorouracil; Folinic acid; Irinotecan; Oxaliplatin
- Indications Adenocarcinoma; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 20 Mar 2017 New trial record
- 21 Jan 2017 Results presented at the 2017 Gastrointestinal Cancers Symposium